Fruzaqla
NDC 63020-210, fruquintinib, capsule, from Takeda Pharmaceuticals America, Inc..
- Product NDC
- 63020-210
- Status
- Listed
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA217564
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63020-210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FRUQUINTINIB1 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63020-210-21 | 63020021021 | 1 BOTTLE in 1 CARTON (63020-210-21) / 21 CAPSULE in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/186d786e-dc8a-45f2-b5e1-01ac0201879f
Use it
Look up 63020-210 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63020-210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63020-210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.